SCHEMBL8706111

SCHEMBL8706111

N=C(NC(=O)c1ccccc1)Nn1cccc1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ GAA P10253 3/20 0.38
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HDAC3 O15379 1/20 0.37
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29943719 0.82 EPHX1 (0.50) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL8700219 0.77 MAPT (0.42) ALDH1A1KMT2ANPC1RAB9AMEN1
Hydrochloric Acid SCHEMBL8699950 0.76 MAPT (0.41) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL6933112 0.75 ALDH1A1 (0.57) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL2060081 0.71 ALDH1A1 (0.51) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL13088685 0.71 ALDH1A1 (0.49) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL8706114 0.70 CYP1A2 (0.39) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL519468 0.70 ALDH1A1 (0.52) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL5674172 0.69 RAB9A (0.57) ALDH1A1KMT2ANPC1RAB9AMEN1
SCHEMBL8634915 0.69 ALDH1A1 (0.55) ALDH1A1KMT2ANPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5824691-A CARDIOVASCULAR, CEREBROVASCULAR, RENAL DISEASES; SHOCK, ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-10-20 — — US disclosed
Send feedback